Mural Oncology (MURA) Competitors $2.07 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$2.08 +0.01 (+0.24%) As of 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MURA vs. FBRX, CABA, IKT, ZNTL, ZURA, CHRS, CGEN, PLX, ACOG, and FATEShould you be buying Mural Oncology stock or one of its competitors? The main competitors of Mural Oncology include Forte Biosciences (FBRX), Cabaletta Bio (CABA), Inhibikase Therapeutics (IKT), Zentalis Pharmaceuticals (ZNTL), Zura Bio (ZURA), Coherus Oncology (CHRS), Compugen (CGEN), Protalix BioTherapeutics (PLX), Alpha Cognition (ACOG), and Fate Therapeutics (FATE). These companies are all part of the "pharmaceutical products" industry. Mural Oncology vs. Its Competitors Forte Biosciences Cabaletta Bio Inhibikase Therapeutics Zentalis Pharmaceuticals Zura Bio Coherus Oncology Compugen Protalix BioTherapeutics Alpha Cognition Fate Therapeutics Mural Oncology (NASDAQ:MURA) and Forte Biosciences (NASDAQ:FBRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Which has stronger valuation & earnings, MURA or FBRX? Forte Biosciences is trading at a lower price-to-earnings ratio than Mural Oncology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMural OncologyN/AN/A-$128.51M-$8.59-0.24Forte BiosciencesN/AN/A-$35.48M-$16.29-0.67 Which has more risk and volatility, MURA or FBRX? Mural Oncology has a beta of 2.99, indicating that its stock price is 199% more volatile than the S&P 500. Comparatively, Forte Biosciences has a beta of 2.69, indicating that its stock price is 169% more volatile than the S&P 500. Do insiders & institutionals hold more shares of MURA or FBRX? 80.2% of Mural Oncology shares are owned by institutional investors. Comparatively, 77.6% of Forte Biosciences shares are owned by institutional investors. 2.2% of Mural Oncology shares are owned by insiders. Comparatively, 5.9% of Forte Biosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer MURA or FBRX? In the previous week, Forte Biosciences had 2 more articles in the media than Mural Oncology. MarketBeat recorded 2 mentions for Forte Biosciences and 0 mentions for Mural Oncology. Forte Biosciences' average media sentiment score of 1.00 beat Mural Oncology's score of 0.00 indicating that Forte Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Mural Oncology Neutral Forte Biosciences Positive Is MURA or FBRX more profitable? Forte Biosciences' return on equity of -85.38% beat Mural Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Mural OncologyN/A -107.76% -87.57% Forte Biosciences N/A -85.38%-72.34% Do analysts prefer MURA or FBRX? Mural Oncology presently has a consensus target price of $12.00, suggesting a potential upside of 479.71%. Forte Biosciences has a consensus target price of $68.00, suggesting a potential upside of 520.44%. Given Forte Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Forte Biosciences is more favorable than Mural Oncology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mural Oncology 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Forte Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryForte Biosciences beats Mural Oncology on 9 of the 13 factors compared between the two stocks. Get Mural Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for MURA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MURA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MURA vs. The Competition Export to ExcelMetricMural OncologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$35.85M$2.54B$5.76B$9.91BDividend YieldN/A48.51%6.66%4.49%P/E Ratio-0.2422.7183.0126.65Price / SalesN/A538.47503.03163.66Price / CashN/A26.3325.7028.92Price / Book0.616.7910.796.52Net Income-$128.51M$32.94M$3.29B$266.21M7 Day PerformanceN/A0.48%0.02%-0.76%1 Month Performance11.89%6.61%7.06%3.83%1 Year Performance-34.29%-0.50%50.09%24.39% Mural Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MURAMural Oncology3.5487 of 5 stars$2.07flat$12.00+479.7%-34.5%$35.85MN/A-0.24119FBRXForte Biosciences3.512 of 5 stars$11.26-0.4%$68.00+503.9%+44.0%$140.00MN/A-0.695Options VolumeGap UpCABACabaletta Bio2.0196 of 5 stars$1.53-3.8%$14.43+843.0%-69.0%$139.94MN/A-0.5650News CoverageIKTInhibikase Therapeutics1.7743 of 5 stars$1.84+4.5%$6.50+253.3%+29.1%$137.11MN/A-0.696Gap UpZNTLZentalis Pharmaceuticals2.4648 of 5 stars$1.85+1.6%$8.20+343.2%-47.1%$133.45M$26.87M-0.82160Positive NewsZURAZura Bio3.0653 of 5 stars$2.03-1.0%$14.00+589.7%-50.2%$131.99MN/A-2.903News CoverageCHRSCoherus Oncology4.1375 of 5 stars$1.13-3.4%$4.68+314.5%-7.4%$131.34M$266.96M0.73330News CoverageAnalyst UpgradeGap UpCGENCompugen2.3774 of 5 stars$1.45+1.4%$4.00+175.9%-26.0%$129.39M$22.14M-6.5970Short Interest ↓PLXProtalix BioTherapeutics3.3776 of 5 stars$1.62+1.3%$15.00+825.9%+49.5%$129.17M$61.95M-12.46200Positive NewsACOGAlpha Cognition2.517 of 5 stars$7.93+2.7%$20.00+152.2%N/A$128.15MN/A-4.96N/AFATEFate Therapeutics3.829 of 5 stars$1.11+1.8%$3.30+197.3%-71.0%$128.02M$13.63M-0.77550 Related Companies and Tools Related Companies Forte Biosciences Competitors Cabaletta Bio Competitors Inhibikase Therapeutics Competitors Zentalis Pharmaceuticals Competitors Zura Bio Competitors Coherus Oncology Competitors Compugen Competitors Protalix BioTherapeutics Competitors Alpha Cognition Competitors Fate Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MURA) was last updated on 9/4/2025 by MarketBeat.com Staff From Our Partners2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Mural Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MURA Stock Alerts